✦ LIBER ✦

Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

✍ Scribed by C. Han; P. S. Masand; S. Krulewicz; K. Peindl; P. Mannelli; I. M. Varia; C.-U. Pae; A. A. Patkar

Book ID: 108849182
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 128 KB
Volume: 34
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2008.00975.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: renzapride treatment of

Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation – a double-blind, randomized, placebo-controlled, study

✍ A. J. LEMBO; F. CREMONINI; N. MEYERS; R. HICKLING 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Treatment of irritable bowel syndrome wi

Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial

✍ A. Madisch; G. Holtmann; K. Plein; J. Hotz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Clinical trial: the effects of a ferment

Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double-blind, controlled study

✍ M. SIMRÉN; L. ÖHMAN; J. OLSSON; U. SVENSSON; K. OHLSON; I. POSSERUD; H. STRID 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Clinical trial: the glucagon-like peptid

Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study

✍ P. M. HELLSTRÖM; J. HEIN; P. BYTZER; E. BJÖRNSSÖN; J. KRISTENSEN; H. SCHAMBYE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Efficacy and safety of topical WBI-1001

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

✍ R. Bissonnette; Y. Poulin; Y. Zhou; J. Tan; H.C. Hong; J. Webster; W. Ip; L. Tan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views